MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Precipio Cash Conversion Cycle 2011-2026 | PRPO
Annual Cash Conversion Cycle Precipio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.19 | -36 | -42.3 | -46.8 | -153 | -600 | -1.11 K | -1.3 K | -644 | 63.6 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.6 | -1.3 K | -386 |
Quarterly Cash Conversion Cycle Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.7 | 17.2 | 16.8 | - | 13.8 | 11.1 | 18.2 | - | -40.9 | -51.6 | -35 | - | -43.8 | -62.6 | -46.5 | - | -36.7 | -58.3 | -58 | - | -49 | -46.8 | -75.1 | - | -145 | -152 | -374 | - | -590 | -630 | -566 | - | -1.05 K | -1.33 K | -1.41 K | - | -311 | -1.36 K | -831 | - | -692 | -678 | -704 | 34.7 | 104 | 63.9 | 85.1 | 78 | 96.8 | 89.5 | 129 | 101 | 161 | 142 | 147 | 80.6 | 114 | 127 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 161 | -1.41 K | -204 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
299 | $ 6.19 | - | $ 182 M |  USA |
 |
DexCom
DXCM
|
133 | $ 67.4 | - | $ 26 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 23.3 | - | $ 251 M |  China |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
49.1 | $ 110.17 | - | $ 13.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 39.34 | - | $ 1.09 B | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.58 | - | $ 2.01 M | USA |
 |
Illumina
ILMN
|
142 | $ 141.07 | - | $ 22.4 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
90.9 | $ 67.56 | - | $ 4.68 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 4.65 | 3.79 % | $ 2.5 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 19.72 | - | $ 484 M | USA |
 |
Natera
NTRA
|
81.5 | $ 234.31 | - | $ 23.1 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 17.13 | - | $ 921 M | USA |
 |
Danaher Corporation
DHR
|
83.5 | $ 238.37 | - | $ 174 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Pacific Biosciences of California
PACB
|
149 | $ 1.94 | - | $ 492 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 12.16 | -5.74 % | $ 345 M |  Israel |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.38 | - | $ 108 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 29.58 | - | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-11.5 | $ 8.1 | - | $ 480 M | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
QIAGEN N.V.
QGEN
|
122 | $ 48.29 | -0.01 % | $ 10.8 B | Niderland |
 |
Exact Sciences Corporation
EXAS
|
130 | $ 102.11 | - | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 27.85 | - | $ 842 M | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Thermo Fisher Scientific
TMO
|
69.8 | $ 618.86 | - | $ 236 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.73 | 0.03 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 35.32 | - | $ 2.11 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 220.91 | - | $ 11.4 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 485.12 | - | $ 31.5 B |  Schweiz |
 |
IQVIA Holdings
IQV
|
78 | $ 242.41 | - | $ 43.9 B | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.62 | - | $ 2.09 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 174.44 | - | $ 19.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 5.46 | - | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 251.81 | - | $ 21.1 B | USA |